nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylic acid—SLC22A11—Furosemide—dilated cardiomyopathy	0.293	0.345	CbGbCtD
Salicylic acid—SLC22A8—Furosemide—dilated cardiomyopathy	0.17	0.201	CbGbCtD
Salicylic acid—SLC22A6—Furosemide—dilated cardiomyopathy	0.119	0.14	CbGbCtD
Salicylic acid—ALB—Furosemide—dilated cardiomyopathy	0.101	0.119	CbGbCtD
Salicylic acid—ABCB1—Lisinopril—dilated cardiomyopathy	0.0878	0.104	CbGbCtD
Salicylic acid—ABCB1—Spironolactone—dilated cardiomyopathy	0.0773	0.0912	CbGbCtD
Salicylic acid—CYP2C9—cardial valve—dilated cardiomyopathy	0.00802	0.494	CbGeAlD
Salicylic acid—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00546	0.0935	CbGpPWpGaD
Salicylic acid—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00495	0.0849	CbGpPWpGaD
Salicylic acid—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00416	0.0713	CbGpPWpGaD
Salicylic acid—Niacin—SLC22A5—dilated cardiomyopathy	0.0039	1	CrCbGaD
Salicylic acid—Lethargy—Spironolactone—dilated cardiomyopathy	0.00358	0.0484	CcSEcCtD
Salicylic acid—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00348	0.0595	CbGpPWpGaD
Salicylic acid—Heartburn—Lisinopril—dilated cardiomyopathy	0.00286	0.0388	CcSEcCtD
Salicylic acid—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00276	0.0374	CcSEcCtD
Salicylic acid—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0027	0.0366	CcSEcCtD
Salicylic acid—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—SDHA—dilated cardiomyopathy	0.00243	0.0417	CbGpPWpGaD
Salicylic acid—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00235	0.0318	CcSEcCtD
Salicylic acid—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00229	0.031	CcSEcCtD
Salicylic acid—Deafness—Furosemide—dilated cardiomyopathy	0.00213	0.0289	CcSEcCtD
Salicylic acid—Lethargy—Furosemide—dilated cardiomyopathy	0.00195	0.0263	CcSEcCtD
Salicylic acid—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00176	0.0239	CcSEcCtD
Salicylic acid—Confusional state—Spironolactone—dilated cardiomyopathy	0.00174	0.0235	CcSEcCtD
Salicylic acid—Somnolence—Spironolactone—dilated cardiomyopathy	0.00153	0.0207	CcSEcCtD
Salicylic acid—Drowsiness—Furosemide—dilated cardiomyopathy	0.00147	0.0199	CcSEcCtD
Salicylic acid—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00142	0.0192	CcSEcCtD
Salicylic acid—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.00138	0.0237	CbGpPWpGaD
Salicylic acid—SLC16A1—cardiac ventricle—dilated cardiomyopathy	0.00137	0.0846	CbGeAlD
Salicylic acid—Urticaria—Spironolactone—dilated cardiomyopathy	0.00137	0.0185	CcSEcCtD
Salicylic acid—SLC16A1—myocardium—dilated cardiomyopathy	0.00129	0.0795	CbGeAlD
Salicylic acid—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00125	0.0169	CcSEcCtD
Salicylic acid—Asthma—Lisinopril—dilated cardiomyopathy	0.00124	0.0167	CcSEcCtD
Salicylic acid—Tinnitus—Furosemide—dilated cardiomyopathy	0.00123	0.0166	CcSEcCtD
Salicylic acid—Pruritus—Spironolactone—dilated cardiomyopathy	0.00122	0.0165	CcSEcCtD
Salicylic acid—SLC16A1—Basigin interactions—ITGB1—dilated cardiomyopathy	0.00121	0.0207	CbGpPWpGaD
Salicylic acid—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00118	0.016	CcSEcCtD
Salicylic acid—Erythema—Furosemide—dilated cardiomyopathy	0.00115	0.0155	CcSEcCtD
Salicylic acid—Dizziness—Spironolactone—dilated cardiomyopathy	0.00114	0.0154	CcSEcCtD
Salicylic acid—Weight increased—Lisinopril—dilated cardiomyopathy	0.00113	0.0152	CcSEcCtD
Salicylic acid—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00112	0.0152	CcSEcCtD
Salicylic acid—Vomiting—Spironolactone—dilated cardiomyopathy	0.00109	0.0148	CcSEcCtD
Salicylic acid—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00109	0.0187	CbGpPWpGaD
Salicylic acid—Rash—Spironolactone—dilated cardiomyopathy	0.00109	0.0147	CcSEcCtD
Salicylic acid—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00108	0.0147	CcSEcCtD
Salicylic acid—Headache—Spironolactone—dilated cardiomyopathy	0.00108	0.0146	CcSEcCtD
Salicylic acid—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00107	0.0184	CbGpPWpGaD
Salicylic acid—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00104	0.0141	CcSEcCtD
Salicylic acid—Nausea—Spironolactone—dilated cardiomyopathy	0.00102	0.0139	CcSEcCtD
Salicylic acid—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000993	0.017	CbGpPWpGaD
Salicylic acid—Hepatitis—Lisinopril—dilated cardiomyopathy	0.000989	0.0134	CcSEcCtD
Salicylic acid—Hallucination—Lisinopril—dilated cardiomyopathy	0.000985	0.0133	CcSEcCtD
Salicylic acid—Confusional state—Furosemide—dilated cardiomyopathy	0.000945	0.0128	CcSEcCtD
Salicylic acid—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—SDHA—dilated cardiomyopathy	0.000944	0.0162	CbGpPWpGaD
Salicylic acid—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000936	0.0127	CcSEcCtD
Salicylic acid—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000923	0.0125	CcSEcCtD
Salicylic acid—SLC16A1—heart—dilated cardiomyopathy	0.000902	0.0555	CbGeAlD
Salicylic acid—Anorexia—Furosemide—dilated cardiomyopathy	0.000893	0.0121	CcSEcCtD
Salicylic acid—Erythema—Lisinopril—dilated cardiomyopathy	0.000861	0.0117	CcSEcCtD
Salicylic acid—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000843	0.0114	CcSEcCtD
Salicylic acid—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000834	0.0143	CbGpPWpGaD
Salicylic acid—Somnolence—Furosemide—dilated cardiomyopathy	0.000833	0.0113	CcSEcCtD
Salicylic acid—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000814	0.011	CcSEcCtD
Salicylic acid—Pain—Furosemide—dilated cardiomyopathy	0.000801	0.0108	CcSEcCtD
Salicylic acid—Constipation—Furosemide—dilated cardiomyopathy	0.000801	0.0108	CcSEcCtD
Salicylic acid—SLCO2B1—heart—dilated cardiomyopathy	0.000776	0.0478	CbGeAlD
Salicylic acid—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000772	0.0105	CcSEcCtD
Salicylic acid—SLC16A1—cardiac atrium—dilated cardiomyopathy	0.000772	0.0475	CbGeAlD
Salicylic acid—Urticaria—Furosemide—dilated cardiomyopathy	0.000744	0.0101	CcSEcCtD
Salicylic acid—ALB—heart—dilated cardiomyopathy	0.00071	0.0437	CbGeAlD
Salicylic acid—Confusional state—Lisinopril—dilated cardiomyopathy	0.000709	0.0096	CcSEcCtD
Salicylic acid—Oedema—Lisinopril—dilated cardiomyopathy	0.000703	0.00952	CcSEcCtD
Salicylic acid—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.000696	0.0119	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000674	0.0115	CbGpPWpGaD
Salicylic acid—Anorexia—Lisinopril—dilated cardiomyopathy	0.00067	0.00907	CcSEcCtD
Salicylic acid—Pruritus—Furosemide—dilated cardiomyopathy	0.000663	0.00898	CcSEcCtD
Salicylic acid—ABCB1—ABC-family proteins mediated transport—ABCC9—dilated cardiomyopathy	0.000651	0.0112	CbGpPWpGaD
Salicylic acid—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000641	0.00868	CcSEcCtD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000634	0.0109	CbGpPWpGaD
Salicylic acid—Somnolence—Lisinopril—dilated cardiomyopathy	0.000625	0.00846	CcSEcCtD
Salicylic acid—Dizziness—Furosemide—dilated cardiomyopathy	0.00062	0.00839	CcSEcCtD
Salicylic acid—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000619	0.00838	CcSEcCtD
Salicylic acid—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000611	0.00827	CcSEcCtD
Salicylic acid—Pain—Lisinopril—dilated cardiomyopathy	0.000601	0.00814	CcSEcCtD
Salicylic acid—Constipation—Lisinopril—dilated cardiomyopathy	0.000601	0.00814	CcSEcCtD
Salicylic acid—Vomiting—Furosemide—dilated cardiomyopathy	0.000596	0.00807	CcSEcCtD
Salicylic acid—Rash—Furosemide—dilated cardiomyopathy	0.000591	0.008	CcSEcCtD
Salicylic acid—Dermatitis—Furosemide—dilated cardiomyopathy	0.00059	0.00799	CcSEcCtD
Salicylic acid—Headache—Furosemide—dilated cardiomyopathy	0.000587	0.00795	CcSEcCtD
Salicylic acid—PTGS1—myocardium—dilated cardiomyopathy	0.00058	0.0357	CbGeAlD
Salicylic acid—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000579	0.00784	CcSEcCtD
Salicylic acid—Urticaria—Lisinopril—dilated cardiomyopathy	0.000558	0.00756	CcSEcCtD
Salicylic acid—Nausea—Furosemide—dilated cardiomyopathy	0.000557	0.00754	CcSEcCtD
Salicylic acid—SLCO2B1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000549	0.0094	CbGpPWpGaD
Salicylic acid—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.000504	0.00864	CbGpPWpGaD
Salicylic acid—Pruritus—Lisinopril—dilated cardiomyopathy	0.000497	0.00673	CcSEcCtD
Salicylic acid—SLC22A11—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000497	0.00851	CbGpPWpGaD
Salicylic acid—SLC16A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000487	0.00835	CbGpPWpGaD
Salicylic acid—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000481	0.00651	CcSEcCtD
Salicylic acid—Dizziness—Lisinopril—dilated cardiomyopathy	0.000465	0.00629	CcSEcCtD
Salicylic acid—SLC22A7—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000451	0.00773	CbGpPWpGaD
Salicylic acid—Vomiting—Lisinopril—dilated cardiomyopathy	0.000447	0.00605	CcSEcCtD
Salicylic acid—CYP2C9—heart—dilated cardiomyopathy	0.000443	0.0273	CbGeAlD
Salicylic acid—Rash—Lisinopril—dilated cardiomyopathy	0.000443	0.006	CcSEcCtD
Salicylic acid—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000443	0.006	CcSEcCtD
Salicylic acid—Headache—Lisinopril—dilated cardiomyopathy	0.00044	0.00596	CcSEcCtD
Salicylic acid—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.000434	0.00744	CbGpPWpGaD
Salicylic acid—Nausea—Lisinopril—dilated cardiomyopathy	0.000418	0.00565	CcSEcCtD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.000413	0.00708	CbGpPWpGaD
Salicylic acid—PTGS1—heart—dilated cardiomyopathy	0.000405	0.0249	CbGeAlD
Salicylic acid—SLC16A1—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.000402	0.00688	CbGpPWpGaD
Salicylic acid—PTGS2—heart—dilated cardiomyopathy	0.000387	0.0238	CbGeAlD
Salicylic acid—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.00038	0.00651	CbGpPWpGaD
Salicylic acid—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000379	0.00649	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000376	0.00645	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.000359	0.00614	CbGpPWpGaD
Salicylic acid—PTGS1—cardiac atrium—dilated cardiomyopathy	0.000346	0.0213	CbGeAlD
Salicylic acid—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.00032	0.00548	CbGpPWpGaD
Salicylic acid—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000319	0.00547	CbGpPWpGaD
Salicylic acid—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000316	0.00542	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000305	0.00522	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—ANKRD1—dilated cardiomyopathy	0.0003	0.00514	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—TTN—dilated cardiomyopathy	0.000294	0.00504	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000287	0.00491	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—TAZ—dilated cardiomyopathy	0.000282	0.00483	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000279	0.00478	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000279	0.00478	CbGpPWpGaD
Salicylic acid—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000275	0.00471	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000264	0.00452	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00026	0.00446	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00026	0.00445	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000259	0.00444	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—SDHA—dilated cardiomyopathy	0.000255	0.00437	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—ACTN2—dilated cardiomyopathy	0.000255	0.00437	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000255	0.00436	CbGpPWpGaD
Salicylic acid—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000253	0.00434	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000253	0.00433	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000253	0.00433	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000248	0.00424	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000248	0.00424	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.000246	0.00421	CbGpPWpGaD
Salicylic acid—ABCB1—heart—dilated cardiomyopathy	0.000239	0.0147	CbGeAlD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000236	0.00404	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000235	0.00402	CbGpPWpGaD
Salicylic acid—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.000234	0.00401	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00023	0.00394	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000229	0.00393	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000229	0.00393	CbGpPWpGaD
Salicylic acid—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.000218	0.00374	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—VCL—dilated cardiomyopathy	0.000217	0.00371	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000213	0.00365	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000213	0.00365	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.000211	0.00362	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.000207	0.00354	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000203	0.00348	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000198	0.00339	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000197	0.00338	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000193	0.0033	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000193	0.0033	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.000193	0.0033	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000186	0.00318	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000184	0.00316	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000179	0.00307	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.000172	0.00295	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000169	0.00289	CbGpPWpGaD
Salicylic acid—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000168	0.00287	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000167	0.00287	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.000167	0.00286	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000165	0.00283	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000165	0.00282	CbGpPWpGaD
Salicylic acid—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000164	0.00282	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.000164	0.00281	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000161	0.00276	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000161	0.00275	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000161	0.00275	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—TAZ—dilated cardiomyopathy	0.000157	0.0027	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000157	0.00268	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—NPPA—dilated cardiomyopathy	0.000156	0.00267	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000156	0.00267	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000155	0.00266	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000153	0.00263	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000152	0.0026	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—PSEN2—dilated cardiomyopathy	0.000151	0.00259	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000149	0.00256	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000147	0.00252	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—SDHA—dilated cardiomyopathy	0.000142	0.00244	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.000142	0.00243	CbGpPWpGaD
Salicylic acid—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000137	0.00235	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000137	0.00234	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000137	0.00234	CbGpPWpGaD
Salicylic acid—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000131	0.00224	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00013	0.00223	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.00013	0.00223	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000127	0.00217	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000121	0.00207	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000119	0.00204	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000117	0.002	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000117	0.002	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000113	0.00194	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—ITGB1—dilated cardiomyopathy	0.000109	0.00186	CbGpPWpGaD
Salicylic acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000108	0.00184	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000106	0.00181	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000104	0.00178	CbGpPWpGaD
Salicylic acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000101	0.00172	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—TTN—dilated cardiomyopathy	9.92e-05	0.0017	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	9.76e-05	0.00167	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.4e-05	0.00161	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.4e-05	0.00161	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—CD36—dilated cardiomyopathy	9.29e-05	0.00159	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	8.79e-05	0.00151	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—RAC1—dilated cardiomyopathy	8.75e-05	0.0015	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.73e-05	0.0015	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	8.6e-05	0.00147	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.59e-05	0.00147	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.46e-05	0.00145	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	8.42e-05	0.00144	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	8.36e-05	0.00143	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	8.36e-05	0.00143	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	8.27e-05	0.00142	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	8.12e-05	0.00139	CbGpPWpGaD
Salicylic acid—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	8.07e-05	0.00138	CbGpPWpGaD
Salicylic acid—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	8.02e-05	0.00137	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	7.96e-05	0.00136	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.77e-05	0.00133	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—RAC1—dilated cardiomyopathy	7.6e-05	0.0013	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.53e-05	0.00129	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	7.48e-05	0.00128	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.32e-05	0.00125	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.32e-05	0.00125	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—VCL—dilated cardiomyopathy	7.32e-05	0.00125	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.22e-05	0.00124	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	6.98e-05	0.0012	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—GPX1—dilated cardiomyopathy	6.93e-05	0.00119	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.85e-05	0.00117	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.81e-05	0.00117	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—CD36—dilated cardiomyopathy	6.75e-05	0.00116	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	6.56e-05	0.00112	CbGpPWpGaD
Salicylic acid—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	6.52e-05	0.00112	CbGpPWpGaD
Salicylic acid—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	6.4e-05	0.0011	CbGpPWpGaD
Salicylic acid—AKR1C1—Metabolism—AGT—dilated cardiomyopathy	6.08e-05	0.00104	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	6.08e-05	0.00104	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	5.97e-05	0.00102	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	5.93e-05	0.00102	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.89e-05	0.00101	CbGpPWpGaD
Salicylic acid—SLC16A1—Hemostasis—RAF1—dilated cardiomyopathy	5.8e-05	0.000994	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	5.75e-05	0.000985	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	5.73e-05	0.000981	CbGpPWpGaD
Salicylic acid—SLCO2B1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.65e-05	0.000968	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	5.65e-05	0.000967	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	5.64e-05	0.000966	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RAC1—dilated cardiomyopathy	5.32e-05	0.000911	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	5.32e-05	0.000911	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—TAZ—dilated cardiomyopathy	5.31e-05	0.00091	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	5.28e-05	0.000904	CbGpPWpGaD
Salicylic acid—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	5.18e-05	0.000888	CbGpPWpGaD
Salicylic acid—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.12e-05	0.000877	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—AGT—dilated cardiomyopathy	5.08e-05	0.000871	CbGpPWpGaD
Salicylic acid—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	5.06e-05	0.000868	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—RAF1—dilated cardiomyopathy	5.04e-05	0.000863	CbGpPWpGaD
Salicylic acid—SLC16A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.02e-05	0.00086	CbGpPWpGaD
Salicylic acid—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	4.95e-05	0.000848	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	4.95e-05	0.000848	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—SDHA—dilated cardiomyopathy	4.8e-05	0.000823	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	4.65e-05	0.000797	CbGpPWpGaD
Salicylic acid—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.65e-05	0.000796	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	4.62e-05	0.000792	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.56e-05	0.000781	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.44e-05	0.000761	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	4.35e-05	0.000744	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	4.21e-05	0.000721	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4e-05	0.000685	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	3.93e-05	0.000673	CbGpPWpGaD
Salicylic acid—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.91e-05	0.000669	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—GPX1—dilated cardiomyopathy	3.87e-05	0.000662	CbGpPWpGaD
Salicylic acid—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.8e-05	0.000651	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—CD36—dilated cardiomyopathy	3.77e-05	0.000645	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	3.74e-05	0.000641	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	3.67e-05	0.000629	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—NPPA—dilated cardiomyopathy	3.63e-05	0.000621	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.62e-05	0.00062	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.62e-05	0.00062	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—RAF1—dilated cardiomyopathy	3.53e-05	0.000604	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.53e-05	0.000604	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—PSEN2—dilated cardiomyopathy	3.51e-05	0.000602	CbGpPWpGaD
Salicylic acid—AKR1C1—Disease—EGFR—dilated cardiomyopathy	3.45e-05	0.000592	CbGpPWpGaD
Salicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.45e-05	0.00059	CbGpPWpGaD
Salicylic acid—SLC16A1—Metabolism—AGT—dilated cardiomyopathy	3.39e-05	0.000581	CbGpPWpGaD
Salicylic acid—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.26e-05	0.000558	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.17e-05	0.000544	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—CD36—dilated cardiomyopathy	3.13e-05	0.000537	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RAC1—dilated cardiomyopathy	2.95e-05	0.000506	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.93e-05	0.000502	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.85e-05	0.000489	CbGpPWpGaD
Salicylic acid—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.57e-05	0.00044	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	2.56e-05	0.000439	CbGpPWpGaD
Salicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	2.44e-05	0.000418	CbGpPWpGaD
Salicylic acid—AKR1C1—Signaling Pathways—EGFR—dilated cardiomyopathy	2.42e-05	0.000414	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.4e-05	0.000411	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.33e-05	0.0004	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.1e-05	0.00036	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	2.03e-05	0.000348	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—CD36—dilated cardiomyopathy	1.98e-05	0.000339	CbGpPWpGaD
Salicylic acid—ALB—Hemostasis—RAF1—dilated cardiomyopathy	1.96e-05	0.000335	CbGpPWpGaD
Salicylic acid—PTGS1—Metabolism—AGT—dilated cardiomyopathy	1.78e-05	0.000305	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RAC1—dilated cardiomyopathy	1.77e-05	0.000303	CbGpPWpGaD
Salicylic acid—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.69e-05	0.00029	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	1.61e-05	0.000276	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—CD36—dilated cardiomyopathy	1.57e-05	0.000269	CbGpPWpGaD
Salicylic acid—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.48e-05	0.000254	CbGpPWpGaD
Salicylic acid—PTGS2—Metabolism—AGT—dilated cardiomyopathy	1.41e-05	0.000242	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—GPX1—dilated cardiomyopathy	1.3e-05	0.000223	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—CD36—dilated cardiomyopathy	1.27e-05	0.000218	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—RAF1—dilated cardiomyopathy	1.17e-05	0.000201	CbGpPWpGaD
Salicylic acid—ALB—Metabolism—AGT—dilated cardiomyopathy	1.14e-05	0.000196	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	1.14e-05	0.000196	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—CD36—dilated cardiomyopathy	1.11e-05	0.000191	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.07e-05	0.000183	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.04e-05	0.000178	CbGpPWpGaD
Salicylic acid—ABCB1—Metabolism—AGT—dilated cardiomyopathy	1e-05	0.000172	CbGpPWpGaD
Salicylic acid—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	9.36e-06	0.00016	CbGpPWpGaD
Salicylic acid—PTGS2—Disease—EGFR—dilated cardiomyopathy	8.03e-06	0.000138	CbGpPWpGaD
